You searched for metabolic diseases - Page 63 of 64

Immenthep Multibacterial Infection Vaccine 2 min

Startup Scout 9 Mar 2018

This Portugese Biotech is Developing a Vaccine for Life-Threatening Multibacterial Infections

…women. The antibodies target GAPDH, an a gene involved in basic metabolic functions. Comment: Being awarded a grant form the Bill and Melinda Gates foundation is no small feat. The…

March 9, 2018 - 2 minutesmins - By Alexander Burik

Best in Biotech 17 Mar 2023

Greener Pastures for Biotech? 7 Great Biotechs from Ireland

…was founded in 2010 and develops a technology platform of bioactive lipids. The semi-synthetic fatty acids it develops can have broad applications, from inflammatory skin diseases to metabolic disorders. Phase…

March 17, 2023 - 5 minutesmins - By Denise Neves Gameiro

photanol cyanobacteria platform synbio bioplastics

News and Trends 12 Dec 2016

Meet Photanol: Harnessing Cyanobacteria’s Powers for Green Chemicals

…concepts, which yielded exciting research like this new carbon-fixing metabolic pathway. It was really great to talk to Gordon and see how these are being brought to the industry. Images:…

December 12, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 1 Oct 2018

Update: Forbion’s Life Science Fund Tops Goal by €90M

…in investing in biotech companies in the spaces of neurodegenerative diseases, inflammation, microbiome, cardiovascular and metabolic disease and fibrosis. 80% of the investment will be reserved for companies in the…

October 1, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

In Depth 13 Dec 2023

Revolutionizing glioblastoma treatment: how CAR-T cell therapy could be used as a cure

…study and the same vaccine. The mice in the study were given two doses of the vaccine, one week apart. The researchers found that in these mice, metabolic changes occurred…

December 13, 2023 - 8 minutesmins - By Willow Shah-Neville

News and Trends 7 Mar 2017

A New Transatlantic Partnership takes on Antibiotic Resistance

…tuberculosis strains by inhibiting the transcriptional regulator EthR, which inhibits the metabolic activation of the established tuberculosis drug ethionamide (ETH). The preclinical candidate has been shown to dramatically increase the…

March 7, 2017 - 2 minutesmins - By Melanie De Almeida

pili tolouse white biotechnology twb bioreactor

Interview 24 May 2018

Sugar-Munching Microbes Put the ‘Eco’ into the Dyeing Industry

…sugar to produce the same amount of colorant,” he explained. Blache didn’t delve too deeply into the details of the company’s technological process, but essentially the process involves engineering metabolic…

May 24, 2018 - 5 minutesmins - By Helen Albert

News and Trends 26 Mar 2020

Silence Therapeutics to Work with AstraZeneca in RNAi Deal Worth up to €3.6B

AstraZeneca is recruiting RNAi specialist Silence Therapeutics to develop treatments for cardiovascular, renal, metabolic, and respiratory diseases. RNA interference, or RNAi, is a relatively new field of medicine in which…

March 26, 2020 - 3 minutesmins - By Laura Cowen

News and Trends 3 Nov 2022

Trial and new drug for Tourette Syndrome after $250M after funding round completed

…in the study were headache, fatigue, somnolence, insomnia and restlessness. Patients in the trial did not have observable evidence of adverse movement or metabolic side effects commonly reported with antipsychotic…

November 3, 2022 - 3 minutesmins - By Liza Laws

Research Integrin beta 3 cellular senescence

More News! 9 Mar 2017

There’s a New Target for Anti-Aging Therapies

…research has revealed that the rising number of senescent cells, which appear during normal ageing, contributes to many age-related diseases. In a new study by Ana O’Loghlen and collegues, integrin-ß3…

March 9, 2017 - 3 minutesmins - By Melanie De Almeida

Startup Scout 27 Apr 2018

This Portuguese Biotech is Developing a Faster Antimicrobial Susceptibility Test

…date, the company has raised €2.7M in grant funding to develop its technology, which uses flow cytometry to detect microbial cell lesions or metabolic changes in bacteria in response to…

April 27, 2018 - 2 minutesmins - By Alexander Burik

In Depth 20 Nov 2024

Hypoparathyroidism: rare endocrine disorder garners attention from biopharma in 2024

Hypoparathyroidism is a rare condition in which the body produces abnormally low levels of a hormone called the parathyroid hormone (PTH), which is key to regulating and maintaining a balance…

November 20, 2024 - 8 minutesmins - By Roohi Mariam Peter

Resources

Categories

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

This Portugese Biotech is Developing a Vaccine for Life-Threatening Multibacterial Infections

Greener Pastures for Biotech? 7 Great Biotechs from Ireland

Meet Photanol: Harnessing Cyanobacteria’s Powers for Green Chemicals

Update: Forbion’s Life Science Fund Tops Goal by €90M

Revolutionizing glioblastoma treatment: how CAR-T cell therapy could be used as a cure

A New Transatlantic Partnership takes on Antibiotic Resistance

Sugar-Munching Microbes Put the ‘Eco’ into the Dyeing Industry

Silence Therapeutics to Work with AstraZeneca in RNAi Deal Worth up to €3.6B

Trial and new drug for Tourette Syndrome after $250M after funding round completed

There’s a New Target for Anti-Aging Therapies

This Portuguese Biotech is Developing a Faster Antimicrobial Susceptibility Test

Hypoparathyroidism: rare endocrine disorder garners attention from biopharma in 2024

Subscribe to our newsletter to get the latest biotech news!

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

The biggest biotech funding rounds in February 2025

Grab your free report on 3D organoids and explore their future potential

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!